NVO ▼ -1.2% - Novo Nordisk A/S $NVO downgraded to Underweight at Morgan Stanley. PT $40 Novo Nordisk fell 1.2% after Morgan Stanley downgraded the stock to Underweight with a price target of $40, signaling the analyst sees limited upside from current levels. 11-SEP-2026 07:41 AM ET